Alan F. Denenberg

Davis Polk advised Equinix, Inc. on its SEC-registered follow-on public offering of 6,069,444 shares of common stock including 791,666 shares that the underwriters purchased pursuant to…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Microchip Technology Incorporated of $1.8 billion aggregate principal amount of…

Davis Polk advised the joint book-running managers in connection with the $125 million public offering of common stock of Coherus BioSciences, Inc. The common stock is listed on the NASDAQ…

Davis Polk advised McKesson Corporation in connection with the offering of $1 billion aggregate principal amount of notes issued by Change Healthcare Holdings, LLC and Change Healthcare…

Davis Polk advised Barclays Capital Inc. as financial adviser to Rightside Group, Ltd. in connection with the $76.7 million sale (after a net working capital adjustment) of its eNom…

Davis Polk is advising Equinix, Inc. on the $3.6 billion acquisition of Verizon Communications Inc.’s colocation services business at 24 data center sites, consisting of 29 data center…

Davis Polk advised Ingram Micro Inc. on the completion of its $6 billion all-cash acquisition by Tianjin Tianhai Investment Company, Ltd., a part of HNA Group, which closed on December 5,…

Davis Polk is advising JP Morgan as financial adviser to Teleflex Incorporated in connection with its approximately $1 billion acquisition of Vascular Solutions, Inc. The closing of the…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $107 million initial public offering by Quantenna Communications, Inc. of 6,700,000…

Davis Polk advised the joint book-running managers in connection with a $100.1 million SEC-registered offering of 3,850,000 ordinary shares of Theravance Biopharma, Inc. The ordinary…